Ocean Biomedical, Inc. celebrated the discovery of bispecific antibodies that target Chitinase 3-like-1 and immune checkpoint inhibitors, killing glioblastoma cells and melanoma cells, and blocking the metastasis of malignant melanoma cells to the lung by over 90%.
[Ocean Biomedical, Inc. (Globe Newswire)]